Drug Approval Package

 Negram (Nalidixic Acid) Caplets & Suspension
Company:  Sanofi-Synthelabo Inc.
Application No.:  014214S050/S051 & 17430s026/S027
Approval Date: 11/23/1999

• Approval Letter(s) (PDF)    

• Printed Labeling (PDF)    

• Medical Review(s) (PDF)    

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)    

• Administrative Document(s) & Correspondence (PDF)  

Date created: August 9, 2004

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.